Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biomerica (BMRA) Net Margin (2016 - 2025)

Biomerica's Net Margin history spans 16 years, with the latest figure at 109.01% for Q4 2025.

  • For Q4 2025, Net Margin fell 5094.0% year-over-year to 109.01%; the TTM value through Nov 2025 reached 90.26%, up 1026.0%, while the annual FY2025 figure was 93.64%, 1676.0% up from the prior year.
  • Net Margin for Q4 2025 was 109.01% at Biomerica, down from 0.14% in the prior quarter.
  • Across five years, Net Margin topped out at 0.14% in Q3 2025 and bottomed at 633.14% in Q2 2021.
  • The 5-year median for Net Margin is 106.47% (2025), against an average of 121.86%.
  • The largest annual shift saw Net Margin plummeted -60315bps in 2021 before it soared 60087bps in 2022.
  • A 5-year view of Net Margin shows it stood at 24.22% in 2021, then tumbled by -353bps to 109.73% in 2022, then increased by 12bps to 96.17% in 2023, then soared by 40bps to 58.07% in 2024, then plummeted by -88bps to 109.01% in 2025.
  • Per Business Quant, the three most recent readings for BMRA's Net Margin are 109.01% (Q4 2025), 0.14% (Q3 2025), and 206.14% (Q2 2025).